FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 122 filers reported holding FLEXION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,000 | – | 56 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $2,000 | -93.5% | 175 | -89.6% | 0.00% | -100.0% |
Q3 2018 | $31,000 | -77.5% | 1,675 | -68.7% | 0.00% | -83.3% |
Q2 2018 | $138,000 | -38.7% | 5,355 | -40.5% | 0.01% | -40.0% |
Q1 2018 | $225,000 | 0.0% | 9,005 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $225,000 | +16.0% | 9,005 | +12.1% | 0.01% | +25.0% |
Q3 2017 | $194,000 | +88.3% | 8,030 | +58.1% | 0.01% | +100.0% |
Q2 2017 | $103,000 | -5.5% | 5,080 | +24.5% | 0.00% | -20.0% |
Q1 2017 | $109,000 | +58.0% | 4,080 | +11.8% | 0.01% | +66.7% |
Q4 2016 | $69,000 | +76.9% | 3,650 | +82.5% | 0.00% | +50.0% |
Q3 2016 | $39,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |